Dyve Biosciences, Inc.   Report issue

For profit Phase 2
Founded: Thousand Oaks CA United States (2014)
Status: No NME R&D (2014)

Organization Overview

First Clinical Trial
2020
NCT04130204
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Dyve Biosciences, Inc.